Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Drug Insight: Aminosalicylates for the treatment of IBD
Ole H. Nielsen
*
,
Lars K. Munck
*
Corresponding author for this work
Department of Clinical Medicine
102
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug Insight: Aminosalicylates for the treatment of IBD'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mesalazine
100%
Aminosalicylates
100%
Crohn's Disease
50%
Sulfasalazine
50%
Chemoprophylactic
50%
Ulcerative Colitis
50%
Per Se
25%
Clinical Evidence
25%
Colorectal Cancer
25%
Remission
25%
Clinical Effect
25%
5-aminosalicylic Acid (5-ASA)
25%
Active Disease
25%
Pharmacology, Toxicology and Pharmaceutical Science
Aminosalicylic Acid
100%
Inflammatory Bowel Disease
100%
Crohn's Disease
33%
Sulfasalazine
33%
Ulcerative Colitis
33%
Diseases
16%
Remission
16%
Colorectal Carcinoma
16%